Skip to main content
All lobbying filings

NATIONAL ASSOCIATION OF MANUFACTURERS

Lobbying for NATIONAL ASSOCIATION OF MANUFACTURERS

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $2,140,000.00 expenses · posted Apr 20, 2026

Official filing document

 Bills named in this filing 6
  • HR 4930
    To expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
  • HR 6687
    DRIVER Act
  • HR 1566
    REPAIR Act
  • HR 4393
    DIGNIDAD (Dignity) Act of 2025
  • HR 5494
    Essential Workers for Economic Advancement Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 19
Chemicals/Chemical Industry

Toxic Substances Control Act (TSCA) Reauthorization

Copyright/Patent/Trademark

Bayh-Dole Act HR 4930, S 2677 re. counterfeiting and customs HR 6687 DRIVER Act HR 1566, REPAIR Act March-in rights NIH Licensing guidelines Patent registration fees Patent royalties proposals

Consumer Issues/Safety/Products

Comprehensive privacy legislation

Defense

National Defense Authorization Act for Fiscal Year 2027

Energy/Nuclear

Critical Minerals Electricity Policy for Manufacturers Energy demand and data centers/AI Energy efficiency ENERGY STAR Greenhouse Gas (GHG) Emissions Liquefied Natural Gas (LNG) exports Nuclear fuel Nuclear licensing Offshore Leasing and energy production Permitting Reform Renewable energy permitting

Environment/Superfund

CAFE Standards Clean Air Act Clean Water ACT Section 401 Clean Water Act WOTUS Definition National Ambient Air Quality Standards (NAAQS)

Financial Institutions/Investments/Securities

Export Import Bank Reauthorization Financial Accounting Standards Board (FASB) income tax disclosures Foreign Private Issuers Proxy advisory firms Shareholder proposal reform

Food Industry (safety, labeling, etc.)

Dietary Guidelines Generally Recognized as Safe - GRAS National Uniformity Nutrition Labeling Ultra-processed Foods

Government Issues

S 2750, SANDBOX Act

Health Issues

340B Reform Compounding Employer-sponsored insurance (including ICHRAs and AHPs) ERISA preemption FDA resourcing Health Savings Accounts Medicare Drug Price Negotiation Program Mergers and acquisitions Most Favored Nation/International Reference Pricing Nonprescription drugs PBM reform SAFE Drugs Act

Homeland Security

Cybersecurity

Immigration

Border security HR 4393, Dignity Act HR 5494, Essential Workers for Economic Advancement Act Immigration enforcement and compliance Immigration reform

Labor Issues/Antitrust/Workplace

Antitrust Policy Independent Contractor Rule Joint Employer Rule NLRB Nominations OSHA Heat Rule Right-to-repair

Manufacturing

Artificial Intelligence Manufacturing workforce development Robotics

Science/Technology

Research & Development

Tariff (miscellaneous tariff bills)

301 investigations and tariffs First Sale bill Agreements on Reciprocal Trade IEEPA tariffs Pharmaceutical tariffs Sec 232 steel and aluminum tariffs and derivatives USMCA

Taxation/Internal Revenue Code

168n Factory Deduction Corporate Alternative Minimum Tax (CAMT) HR 1 Business Tax Provisions Interest Expensing ATI Definition R&D Tax Credit Side-by-side international tax agreement Strategy Energy and Manufacturing Tax Credits

Transportation

Surface Transportation Reauthorization

Trade (domestic/foreign)

AI technology exports Auto Sec 232 China Export-Import Bank Reauthorization Impact of Tariffs on Manufacturing Inputs Inclusions process Machinery and robotics Sec 232 Sec 232 pharma

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem